Tradestie Institutional Equity Comparison Engine
LTBR vs ASTH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ASTH Overall Edge
ASTH Captures Institutional Edge (4โ0 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Astrana Health Inc. Common Stock (ASTH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, LTBR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ASTH at 9.1x Forward P/E and 2.6% operating margin (+7.1% YoY). In options structure, LTBR sits in BREAKDOWN (32nd %ile IV; Dealer Gamma Walls on Pro) against ASTH sits in BREAKDOWN (11th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ASTH
LTBR N/M vs ASTH 9.1x Fwd P/E
Growth & Margin Winner
ASTH
Op Margin 0.0% vs 2.6% ยท YoY +0.0% vs +7.1%
Momentum & Technical Winner
ASTH
1Y -78.6% vs +50.3% ยท 52W Pos 0% vs 44%
Options & Structure Winner
ASTH
BREAKDOWN (32nd %ile IV) vs BREAKDOWN (11th %ile IV)
LTBR
NASDAQ
Lightbridge Corp.
Services-Management Consulting Services
$3.84
-6.34% 1D
Market Cap
$164.7M
1M Return
-26.3%
1Y Return
-78.62%
Forward P/E
N/M
Unified AI Score
40.4 / 100
SELL
Tech 33.0
Fund 50.0
Flow 56.0
Mom 64.0
ASTH
NASDAQ
Astrana Health Inc. Common Stock
Services-Management Consulting Services
$32.94
+3.58% 1D
Market Cap
$1.6B
1M Return
-10.51%
1Y Return
+50.34%
Forward P/E
9.1x
Unified AI Score
53.2 / 100
HOLD
Tech 59.0
Fund 56.0
Flow 59.0
Mom 56.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
LTBR -78.62%
ASTH +50.34%
Spread: +128.96 pp (ASTH Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | LTBR Revenue | ASTH Revenue | LTBR Op. Margin | ASTH Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $520M | N/A | 17.0% | ASTH |
| FY2019 | N/A | $560M | N/A | 5.8% | ASTH |
| FY2020 | N/A | $690M | N/A | 11.7% | ASTH |
| FY2021 | N/A | $770M | N/A | 12.7% | ASTH |
| FY2022 | N/A | $1.14B | N/A | 9.1% | ASTH |
| FY2023 | N/A | $1.39B | N/A | 6.1% | ASTH |
| FY2024 | N/A | $2.03B | N/A | 4.4% | ASTH |
| FY2025 | N/A | $3.18B | N/A | 2.5% | ASTH |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | LTBR | ASTH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $164.7M | $1.6B | Larger Scale | ASTH |
| Trailing P/E Ratio Valuation | N/M | 30.6x | Lower Multiple | ASTH |
| Forward P/E Ratio Valuation | N/M | 9.1x | Lower Multiple | ASTH |
| Revenue Growth (YoY) Growth | +0.0% | +7.1% | Higher Growth | ASTH |
| Operating Margin (TTM) Profitability | 0.0% | 2.6% | Higher Margin | ASTH |
| Net Profit Margin Profitability | 0.0% | 1.4% | Higher Margin | ASTH |
| Return on Equity (ROE) Capital Efficiency | -14.1% | 9.8% | Higher ROE | ASTH |
| 52-Week Range Position Momentum | 0% ($4โ$20) | 44% ($18โ$52) | Stronger Trend | ASTH |
| Beta / 30D Volatility Risk Regime | 3.45ฮฒ ยท 98% Vol | 0.40ฮฒ ยท 60% Vol | Lower Realized Risk | ASTH |
| Unified Institutional Score Composite Signal | 40.4 / 100 (SELL) | 53.2 / 100 (HOLD) | Higher Composite | ASTH |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full LTBR vs ASTH Buy Guide
LTBR
BREAKDOWN
134d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
32nd %ile
IV Regime
Balanced (25thโ60th %ile)
ASTH
BREAKDOWN
96d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
11th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither LTBR nor ASTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.